Works matching IS 15747891 AND DT 2023 AND VI 17 AND IP 10

Results: 20

Breaking barriers in breast cancer therapy.
Published in:
Molecular Oncology, 2023, v. 17, n. 10, p. 1945, doi. 10.1002/1878-0261.13532
By:
- Maniyar, Siddhi;
- Tsagakis, Ioannis
Publication type:
Article
From bedside to portable and wearable: development of a conformable ultrasound patch for deep breast tissue imaging.
Published in:
Molecular Oncology, 2023, v. 17, n. 10, p. 1947, doi. 10.1002/1878-0261.13531
By:
- Burgess, Mark T.;
- Gluskin, Jill;
- Pinker, Katja
Publication type:
Article
Hot on RAD51C: structure and functions of RAD51C‐XRCC3.
Published in:
Molecular Oncology, 2023, v. 17, n. 10, p. 1950, doi. 10.1002/1878-0261.13518
By:
- Szakal, Barnabas;
- Branzei, Dana
Publication type:
Article
Assay‐agnostic spatial profiling detects tumor microenvironment signatures: new diagnostic insights for triple‐negative breast cancer.
Published in:
Molecular Oncology, 2023, v. 17, n. 10, p. 1953, doi. 10.1002/1878-0261.13515
By:
- Ziegler, Colleen;
- Mir, Alain;
- Anandakrishnan, Sangeetha;
- Martin, Patrick;
- Contreras, Elma;
- Slemons, Isaiah;
- Witkowski, Barbara;
- DeSilva, Chris;
- Farmer, Andrew;
- Vranic, Semir;
- Gatalica, Zoran;
- Richardson, David;
- Derkach, Dmitry N.
Publication type:
Article
Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparity.
Published in:
Molecular Oncology, 2023, v. 17, n. 10, p. 2183, doi. 10.1002/1878-0261.13511
By:
- Wei, Yu;
- Zhang, Tingwei;
- Wang, Beihe;
- Pan, Jian;
- Jin, Shengming;
- Fang, Bangwei;
- Gu, Weijie;
- Qin, Xiaojian;
- Dai, Bo;
- Lin, Guowen;
- Gan, Hualei;
- Wu, Junlong;
- Ye, Dingwei;
- Zhu, Yao
Publication type:
Article
Novel insights into molecular patterns of ROS1 fusions in a large Chinese NSCLC cohort: a multicenter study.
Published in:
Molecular Oncology, 2023, v. 17, n. 10, p. 2200, doi. 10.1002/1878-0261.13509
By:
- Zhou, Shengyu;
- Zhang, Fayan;
- Xu, Mengxiang;
- Zhang, Lei;
- Liu, Zhengchuang;
- Yang, Qiong;
- Wang, Chunyang;
- Wang, Baoming;
- Ma, Tonghui;
- Feng, Jiao
Publication type:
Article
Cadherin‐11 increases tumor cell proliferation and metastatic potential via Wnt pathway activation.
Published in:
Molecular Oncology, 2023, v. 17, n. 10, p. 2056, doi. 10.1002/1878-0261.13507
By:
- Liu, Yayu;
- Lei, Pedro;
- Samuel, Ronel Z.;
- Kashyap, Anagha M.;
- Groth, Theodore;
- Bshara, Wiam;
- Neelamegham, Sriram;
- Andreadis, Stelios T.
Publication type:
Article
Interaction between membranous EBP50 and myosin 9 as a favorable prognostic factor in ovarian clear cell carcinoma.
Published in:
Molecular Oncology, 2023, v. 17, n. 10, p. 2168, doi. 10.1002/1878-0261.13503
By:
- Nakagawa, Mayu;
- Matsumoto, Toshihide;
- Yokoi, Ako;
- Hashimura, Miki;
- Oguri, Yasuko;
- Konno, Ryo;
- Ishibashi, Yu;
- Ito, Takashi;
- Ohhigata, Kensuke;
- Harada, Yohei;
- Fukagawa, Naomi;
- Kodera, Yoshio;
- Saegusa, Makoto
Publication type:
Article
Promyelocytic leukemia protein regulates angiogenesis and epithelial–mesenchymal transition to limit metastasis in MDA‐MB‐231 breast cancer cells.
Published in:
Molecular Oncology, 2023, v. 17, n. 10, p. 2090, doi. 10.1002/1878-0261.13501
By:
- Vogiatzoglou, Amalia P.;
- Spanou, Syrago;
- Sachini, Nikoleta;
- Drakos, Elias;
- Nikolaou, Christoforos;
- Makatounakis, Takis;
- Kretsovali, Androniki;
- Papamatheakis, Joseph
Publication type:
Article
Lysosome‐dependent FOXA1 ubiquitination contributes to luminal lineage of advanced prostate cancer.
Published in:
Molecular Oncology, 2023, v. 17, n. 10, p. 2126, doi. 10.1002/1878-0261.13497
By:
- Celada, Sherly I.;
- Li, Guoliang;
- Celada, Lindsay J.;
- Lu, Wenfu;
- Kanagasabai, Thanigaivelan;
- Feng, Weiran;
- Cao, Zhen;
- Salsabeel, Nazifa;
- Mao, Ninghui;
- Brown, LaKendria K.;
- Mark, Zaniya A.;
- Izban, Michael G.;
- Ballard, Billy R.;
- Zhou, Xinchun;
- Adunyah, Samuel E.;
- Matusik, Robert J.;
- Wang, Xiaofei;
- Chen, Zhenbang
Publication type:
Article
Integrative analysis of mRNA and miRNA expression profiles and somatic variants in oxysterol signaling in early‐stage luminal breast cancer.
Published in:
Molecular Oncology, 2023, v. 17, n. 10, p. 2074, doi. 10.1002/1878-0261.13495
By:
- Holý, Petr;
- Brynychová, Veronika;
- Šeborová, Karolína;
- Haničinec, Vojtěch;
- Koževnikovová, Renata;
- Trnková, Markéta;
- Vrána, David;
- Gatěk, Jiří;
- Kopečková, Kateřina;
- Mrhalová, Marcela;
- Souček, Pavel
Publication type:
Article
Osteoblast‐derived extracellular vesicles exert osteoblastic and tumor‐suppressive functions via SERPINA3 and LCN2 in prostate cancer.
Published in:
Molecular Oncology, 2023, v. 17, n. 10, p. 2147, doi. 10.1002/1878-0261.13484
By:
- Ito, Kagenori;
- Yamamoto, Tomofumi;
- Hayashi, Yusuke;
- Sato, Shun;
- Nakayama, Jun;
- Urabe, Fumihiko;
- Shimasaki, Takeo;
- Nakamura, Eijiro;
- Matui, Yoshiyuki;
- Fujimoto, Hiroyuki;
- Kimura, Takahiro;
- Egawa, Shin;
- Ochiya, Takahiro;
- Yamamoto, Yusuke
Publication type:
Article
Functional inhibition of the RNA‐binding protein HuR sensitizes triple‐negative breast cancer to chemotherapy.
Published in:
Molecular Oncology, 2023, v. 17, n. 10, p. 1962, doi. 10.1002/1878-0261.13478
By:
- Wei, Lanjing;
- Zhang, Qi;
- Zhong, Cuncong;
- He, Lily;
- Zhang, Yuxia;
- Armaly, Ahlam M.;
- Aubé, Jeffrey;
- Welch, Danny R.;
- Xu, Liang;
- Wu, Xiaoqing
Publication type:
Article
Liver X receptors induce antiproliferative effects in basal‐like breast cancer.
Published in:
Molecular Oncology, 2023, v. 17, n. 10, p. 2041, doi. 10.1002/1878-0261.13476
By:
- Haugen, Mads Haugland;
- von der Lippe Gythfeldt, Hedda;
- Egeland, Eivind Valen;
- Svartdal Normann, Lisa;
- Pandya, Abhilash D.;
- Vedin, Lise‐Lotte;
- Juell, Siri;
- Tenstad, Ellen;
- Øy, Geir Frode;
- Kristian, Alexandr;
- Marangoni, Elisabetta;
- Sørlie, Therese;
- Steffensen, Knut;
- Mælandsmo, Gunhild Mari;
- Engebraaten, Olav
Publication type:
Article
Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic–mitochondrial tricarboxylic acid cycle that can be targeted for therapeutic purposes in prostate cancer.
Published in:
Molecular Oncology, 2023, v. 17, n. 10, p. 2109, doi. 10.1002/1878-0261.13441
By:
- Gonthier, Kevin;
- Weidmann, Cindy;
- Berthiaume, Line;
- Jobin, Cynthia;
- Lacouture, Aurélie;
- Lafront, Camille;
- Harvey, Mario;
- Neveu, Bertrand;
- Loehr, Jérémy;
- Bergeron, Alain;
- Fradet, Yves;
- Lacombe, Louis;
- Riopel, Julie;
- Latulippe, Éva;
- Atallah, Chantal;
- Shum, Michael;
- Lambert, Jean‐Philippe;
- Pouliot, Frédéric;
- Pelletier, Martin;
- Audet‐Walsh, Étienne
Publication type:
Article
Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer: a long‐term follow‐up of the SweBCG91RT randomized trial.
Published in:
Molecular Oncology, 2023, v. 17, n. 10, p. 2029, doi. 10.1002/1878-0261.13426
By:
- Egelberg, Moa;
- De Marchi, Tommaso;
- Pekar, Gyula;
- Tran, Lena;
- Bendahl, Pär‐Ola;
- Tullberg, Axel Stenmark;
- Holmberg, Erik;
- Karlsson, Per;
- Farnebo, Marianne;
- Killander, Fredrika;
- Nimeús, Emma
Publication type:
Article
Ebselen oxide and derivatives are new allosteric HER2 inhibitors for HER2‐positive cancers.
Published in:
Molecular Oncology, 2023, v. 17, n. 10, p. 1981, doi. 10.1002/1878-0261.13419
By:
- Blasquez, Lucas;
- Bouzinba‐Segard, Haniaa;
- Bourdoulous, Sandrine;
- Faure, Camille
Publication type:
Article
HORMAD1 overexpression predicts response to anthracycline–cyclophosphamide and survival in triple‐negative breast cancers.
Published in:
Molecular Oncology, 2023, v. 17, n. 10, p. 2017, doi. 10.1002/1878-0261.13412
By:
- El‐Botty, Rania;
- Vacher, Sophie;
- Mainguené, Juliette;
- Briaux, Adrien;
- Ibadioune, Sabrina;
- Dahmani, Ahmed;
- Montaudon, Elodie;
- Nemati, Fariba;
- Huguet, Léa;
- Sourd, Laura;
- Morriset, Ludivine;
- Château‐Joubert, Sophie;
- Dubois, Thierry;
- Maire, Virginie;
- Lidereau, Rosette;
- Rapinat, Audrey;
- Gentien, David;
- Coussy, Florence;
- Bièche, Ivan;
- Marangoni, Elisabetta
Publication type:
Article
Issue Information.
Published in:
Molecular Oncology, 2023, v. 17, n. 10, p. 1943, doi. 10.1002/1878-0261.13240
Publication type:
Article
ER+, HER2− advanced breast cancer treated with taselisib and fulvestrant: genomic landscape and associated clinical outcomes.
Published in:
Molecular Oncology, 2023, v. 17, n. 10, p. 2000, doi. 10.1002/1878-0261.13416
By:
- Chen, Jessica W.;
- Jacot, William;
- Cortés, Javier;
- Krop, Ian E.;
- Dent, Susan;
- Harbeck, Nadia;
- De Laurentiis, Michelino;
- Diéras, Véronique;
- Im, Young‐Hyuck;
- Stout, Thomas J.;
- Schimmoller, Frauke;
- Savage, Heidi M.;
- Hutchinson, Katherine E.;
- Wilson, Timothy R.
Publication type:
Article